Basal cell carcinoma responding to systemic 5-fluorouracil

Basal Cell Carcinoma

“…Most of the aggressive BCC lesions of the patient which had not responded to treatment with intravenous cisplatin healed after 19 cycles intravenous paclitaxel treatment (Russo, 2005). Snipes et al reported that there was improvement with systemic 5-fluorouracil(5-FU) in a 52-year-old male patient with nodular BCC (Snipes et al, 2006).…”